A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
Planting A, Kho S, van der Burg M, Goey H, Schellens J, van den Bent M, van der Gaast A, de Boer-Dennert M, Stoter G, Verweij J.
Planting A, et al. Among authors: van den bent m, van der burg m, van der gaast a.
Cancer Chemother Pharmacol. 1997;40(4):347-52. doi: 10.1007/s002800050668.
Cancer Chemother Pharmacol. 1997.
PMID: 9225954
Free article.
Clinical Trial.